Geert Cauwenbergh joins RXi as CEO
RNAi focused biotech, RXi Pharmaceuticals, has appointed Dr Geert Cauwenbergh president and CEO and a member of the board of directors. Dr Cauwenbergh was most recently chair and CEO of Barrier Therapeutics.
RNAi focused biotech, RXi Pharmaceuticals, has appointed Dr Geert Cauwenbergh president and CEO and a member of the board of directors. Dr Cauwenbergh was most recently chair and CEO of Barrier Therapeutics.